Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Original Investigation titled “Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial,”1 published online May 2, 2018, the points indicating intravitreal aflibercept injection plus sham photodynamic therapy and intravitreal aflibercept injection plus active photodynamic therapy in panel A of Figure 2 were transposed. This article was corrected online.
Error in Figure 2. JAMA Ophthalmol. 2018;136(7):840. doi:10.1001/jamaophthalmol.2018.2864
Create a personal account or sign in to: